Real world data reflects actual outcomes within the setting of clinical care in a wider context than the randomised clinical trial. While offering much promise to understanding the effectiveness of treatments in patient populations, such data brings in a host of challenges ranging from quality, via ethics to “big data” style informatics requirements. This meeting will explore the regulatory framework that is increasingly developing to govern the use of personal data in the health domain, as well larger scale momentous political changes globally and within Europe since 2016 impacting on healthcare overall. Ultimately, the utilisation of real world data remains open to discussion, conjecture and for some controversy, so illustrative use cases are critical in continuing the debate.
Full program available here